Notify me when Mark E. Strome files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZIVO | Zivo Bioscience, Inc. | Common Stock, par value $.001 per share | 12.2% | $53.1K | 443K | Mark E. Strome | Dec 26, 2024 | ||
| CUE | Cue Biopharma, Inc. | Common Stock, $0.001 par value per share | 4.99% | $1.86M | 2.17M | Mark E. Strome | Nov 14, 2022 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|